163 results on '"Shih DM"'
Search Results
2. Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.
3. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
4. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
5. Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease.
6. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.
7. Role of the Microbiome in Gut-Heart-Kidney Cross Talk.
8. Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms.
9. Can increased intestinal permeability and low-grade endotoxemia be the triggering pathogenesis in isolated coronary artery ectasia?
10. Diet, Microbes, and Murine Atherosclerosis: Complexity?.
11. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study.
12. The roles of PON1 and PON2 in cardiovascular disease and innate immunity.
13. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?
14. Decreased Obesity and Atherosclerosis in Human Paraoxonase 3 Transgenic Mice.
15. Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals.
16. Polymorphisms in the human paraoxonase (PON1) promoter.
17. Perinatal Administration of C-Phycocyanin Protects Against Atherosclerosis in apoE-Deficient Mice by Modulating Cholesterol and Trimethylamine-N-Oxide Metabolisms.
18. Electronic and Tobacco Cigarettes Alter Polyunsaturated Fatty Acids and Oxidative Biomarkers.
19. Human PON3, Effects Beyond the HDL.
20. HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
21. The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.
22. Gut Microbiota and Cardiovascular Disease.
23. Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans.
24. Pro-Oxidative and Proinflammatory Effects After Traveling From Los Angeles to Beijing: A Biomarker-Based Natural Experiment.
25. Gut microbiome and cardiovascular disease.
26. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
27. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals.
28. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
29. Genetic Susceptibility to Atherosclerosis : Insights From Mice.
30. Pro-Oxidative and Proinflammatory Effects After Traveling From Los Angeles to Beijing: A Biomarker-Based Natural Experiment.
31. Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice.
32. Coronary heart disease and intestinal microbiota.
33. Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus: The DCCT/EDIC Study.
34. Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.
35. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk: A Cross-Sectional Study.
36. Genetic Deficiency of Flavin-Containing Monooxygenase 3 (Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels—Brief Report.
37. Lysed Erythrocyte Membranes Promote Vascular Calcification: Possible Role of Erythrocyte-Derived Nitric Oxide.
38. Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism.
39. Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.
40. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential.
41. Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe−/− Mice.
42. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
43. Gut Microbiota–Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
44. Transcription Factor Zhx2 Deficiency Reduces Atherosclerosis and Promotes Macrophage Apoptosis in Mice.
45. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
46. HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.
47. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe−/− Mice.
48. Cardiovascular Metabolomics.
49. Cilostazol Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E–Deficient Mice.
50. Reactive Oxygen Species in Metabolic and Inflammatory Signaling.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.